Kynurenine‐3‐monooxygenase: A new direction for the treatment in different diseases
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Kynurenine‐3‐monooxygenase: A new direction for the treatment in different diseases
Authors
Keywords
-
Journal
Food Science & Nutrition
Volume 8, Issue 2, Pages 711-719
Publisher
Wiley
Online
2020-01-21
DOI
10.1002/fsn3.1418
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Kynurenine 3-Monooxygenase Activity in Human Primary Neurons and Effect on Cellular Bioenergetics Identifies New Neurotoxic Mechanisms
- (2019) Gloria Castellano-Gonzalez et al. NEUROTOXICITY RESEARCH
- Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia
- (2019) Jochen Kindler et al. MOLECULAR PSYCHIATRY
- Overexpression of Kynurenine 3-Monooxygenase Correlates with Cancer Malignancy and Predicts Poor Prognosis in Canine Mammary Gland Tumors
- (2019) Yi-Han Chiu et al. Journal of Oncology
- Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau
- (2019) Kelly R. Jacobs et al. NEUROBIOLOGY OF AGING
- Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease
- (2019) Pratishtha Chatterjee et al. Journal of Neuroinflammation
- Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma
- (2019) Soudabeh Rad Pour et al. Scientific Reports
- Biochemistry and structural studies of kynurenine 3-monooxygenase reveal allosteric inhibition by Ro 61-8048
- (2018) Jingjing Gao et al. FASEB JOURNAL
- Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson’s Disease
- (2018) Kuo-Hsuan Chang et al. MOLECULAR NEUROBIOLOGY
- Increasing kynurenine brain levels reduces ethanol consumption in mice by inhibiting dopamine release in nucleus accumbens
- (2018) Pablo Giménez-Gómez et al. NEUROPHARMACOLOGY
- Effect of wedelolactone and gallic acid on quinolinic acid-induced neurotoxicity and impaired motor function: significance to sporadic amyotrophic lateral sclerosis
- (2018) Maya S et al. NEUROTOXICOLOGY
- The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia
- (2018) Gislaine Z. Réus et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation
- (2018) Allison M. Garrison et al. PSYCHONEUROENDOCRINOLOGY
- The Kynurenine 3-Monooxygenase Encoding Gene, BcKMO, Is Involved in the Growth, Development, and Pathogenicity of Botrytis cinerea
- (2018) Kang Zhang et al. Frontiers in Microbiology
- Pharmacological Inhibition of Indoleamine 2,3-Dioxygenase-2 and Kynurenine 3-Monooxygenase, Enzymes of the Kynurenine Pathway, Significantly Diminishes Neuropathic Pain in a Rat Model
- (2018) Ewelina Rojewska et al. Frontiers in Pharmacology
- Kynurenine 3-Monooxygenase Gene Associated With Nicotine Initiation and Addiction: Analysis of Novel Regulatory Features at 5′ and 3′-Regions
- (2018) Hassan A. Aziz et al. Frontiers in Genetics
- Development of a Rapid Fluorescence-Based High-Throughput Screening Assay to Identify Novel Kynurenine 3-Monooxygenase Inhibitor Scaffolds
- (2018) K. R. Jacobs et al. SLAS Discovery
- Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia
- (2018) Sarah Beggiato et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease
- (2018) Yung-Shuan Lin et al. Scientific Reports
- Absence of kynurenine 3-monooxygenase reduces mortality of acute viral myocarditis in mice
- (2017) Hisako Kubo et al. IMMUNOLOGY LETTERS
- Kynurenine Pathway Metabolites in Alzheimer’s Disease
- (2017) Lasse Melvaer Giil et al. JOURNAL OF ALZHEIMERS DISEASE
- Development of a Series of Kynurenine 3-Monooxygenase Inhibitors Leading to a Clinical Candidate for the Treatment of Acute Pancreatitis
- (2017) Ann L. Walker et al. JOURNAL OF MEDICINAL CHEMISTRY
- Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis
- (2017) Jong-Min Lee et al. NEUROPHARMACOLOGY
- Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase
- (2017) Jonathan P. Hutchinson et al. Nature Communications
- The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat
- (2017) Gábor Nagy-Grócz et al. Frontiers in Neurology
- Kynurenine-3-monooxygenase: a review of structure, mechanism, and inhibitors
- (2016) Jason R. Smith et al. DRUG DISCOVERY TODAY
- The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease
- (2016) Vahri Beaumont et al. EXPERIMENTAL NEUROLOGY
- Loss of Kynurenine 3-Mono-oxygenase Causes Proteinuria
- (2016) R. Korstanje et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis
- (2016) Damian J Mole et al. NATURE MEDICINE
- KMO inhibitor for multi-organ failure in experimental acute pancreatitis
- (2016) Katrina Ray Nature Reviews Gastroenterology & Hepatology
- Pharmacological kynurenine 3-monooxygenase enzyme inhibition significantly reduces neuropathic pain in a rat model
- (2016) Ewelina Rojewska et al. NEUROPHARMACOLOGY
- Overexpression of human kynurenine-3-monooxygenase protects against 3-hydroxykynurenine-mediated apoptosis through bidirectional nonlinear feedback
- (2016) K Wilson et al. Cell Death & Disease
- Increased levels of 3-hydroxykynurenine parallel disease severity in human acute pancreatitis
- (2016) Christos Skouras et al. Scientific Reports
- Elevation of Kynurenine Metabolites in Rat Liver and Serum: A Potential Additional Mechanism of the Alcohol Aversive and Anti-cancer Effects of Disulfiram?
- (2015) Abdulla A.-B. Badawy et al. ALCOHOL AND ALCOHOLISM
- Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine
- (2015) C.M. Forrest et al. NEUROSCIENCE
- The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation
- (2015) Marie Favennec et al. Obesity
- The kynurenine pathway and neurodegenerative disease
- (2015) Daniel C. Maddison et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Kynurenine Monooxygenase (KMO) Inhibitors for the Treatment of Acute Pancreatitis and Neurodegenerative Disorders
- (2015) Ahmed F. Abdel-Magid ACS Medicinal Chemistry Letters
- Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration and invasion of human hepatocellular carcinoma
- (2015) Haojie Jin et al. Scientific Reports
- Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology
- (2015) Jennifer M. Parrott et al. Frontiers in Psychiatry
- Kynurenine 3-monooxygenase mediates inhibition of Th17 differentiation via catabolism of endogenous aryl hydrocarbon receptor ligands
- (2013) Geoffrey L. Stephens et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Targeted Deletion of Kynurenine 3-Monooxygenase in Mice
- (2013) Flaviano Giorgini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural basis of kynurenine 3-monooxygenase inhibition
- (2013) Marta Amaral et al. NATURE
- Bacterial expression of human kynurenine 3-monooxygenase: Solubility, activity, purification
- (2013) K. Wilson et al. PROTEIN EXPRESSION AND PURIFICATION
- Downregulated Kynurenine 3-Monooxygenase Gene Expression and Enzyme Activity in Schizophrenia and Genetic Association With Schizophrenia Endophenotypes
- (2011) Ikwunga Wonodi ARCHIVES OF GENERAL PSYCHIATRY
- Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
- (2011) Daniel Zwilling et al. CELL
- The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease
- (2011) Susanna Campesan et al. CURRENT BIOLOGY
- Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls
- (2011) Maria Holtze JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Kynurenine and its metabolites in Alzheimer's disease patients
- (2010) E Gulaj et al. Advances in Medical Sciences
- Dual role of the carboxyl-terminal region of pig liver L-kynurenine 3-monooxygenase: mitochondrial-targeting signal and enzymatic activity
- (2010) K. Hirai et al. JOURNAL OF BIOCHEMISTRY
- Dysfunctional kynurenine pathway metabolism in the R6/2 mouse model of Huntington’s disease
- (2010) Korrapati V. Sathyasaikumar et al. JOURNAL OF NEUROCHEMISTRY
- Characterization of the kynurenine pathway in NSC-34 cell line: implications for amyotrophic lateral sclerosis
- (2010) Yiquan Chen et al. JOURNAL OF NEUROCHEMISTRY
- Alzheimer's disease: strategies for disease modification
- (2010) Martin Citron NATURE REVIEWS DRUG DISCOVERY
- Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia
- (2010) K. V. Sathyasaikumar et al. SCHIZOPHRENIA BULLETIN
- Kynurenine 3-monooxygenase (KMO) polymorphisms in schizophrenia: An association study
- (2010) Maria Holtze et al. SCHIZOPHRENIA RESEARCH
- On the relationship between the two branches of the kynurenine pathway in the rat brainin vivo
- (2009) Laura Amori et al. JOURNAL OF NEUROCHEMISTRY
- The Kynurenine Pathway and Inflammation in Amyotrophic Lateral Sclerosis
- (2009) Yiquan Chen et al. NEUROTOXICITY RESEARCH
- Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: A role for IFN-γ?
- (2008) Thomas J. Connor et al. NEUROSCIENCE LETTERS
- Kynurenine 3-Hydroxylase Inhibition in Rats
- (2003) Jutta Urenjak et al. JOURNAL OF NEUROCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More